Drug profile · INN
potassium phosphate, dibasic
POTASSIUM PHOSPHATES
potassium phosphate, dibasic (POTASSIUM PHOSPHATES) is an FDA-listed pharmaceutical active ingredient. Associated with Regeneron Ireland Designated Activity Company (DAC). Route of administration: intravenous. Current US regulatory status: approved.
Drug details — potassium phosphate, dibasic
- US status
- approved
- Class
- —
- Route
- INTRAVENOUS
- Patents
- 0
- Programs
- 3
- Data quality
- 0.89
Quick answer
potassium phosphate, dibasic (POTASSIUM PHOSPHATES) is an FDA-listed pharmaceutical active ingredient. Associated with Regeneron Ireland Designated Activity Company (DAC). Route of administration: intravenous. Current US regulatory status: approved.
Key facts
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
Pipeline programs
Frequently asked questions
What is potassium phosphate, dibasic?
potassium phosphate, dibasic (POTASSIUM PHOSPHATES) is an FDA-listed pharmaceutical active ingredient. Associated with Regeneron Ireland Designated Activity Company (DAC). Route of administration: intravenous. Current US regulatory status: approved.
What is the brand name for potassium phosphate, dibasic?
POTASSIUM PHOSPHATES is a marketed brand name for potassium phosphate, dibasic. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of potassium phosphate, dibasic?
potassium phosphate, dibasic has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.